Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients
2024

Early Immune Response to Anti-PD1 Therapy in Lung Cancer Patients

Sample size: 48 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gelibter Alain, Tuosto Lucrezia, Asquino Angela, Siringo Marco, Sabatini Arianna, Zizzari Ilaria Grazia, Pace Angelica, Scirocchi Fabio, Valentino Flavio, Bianchini Serena, Caponnetto Salvatore, Paoli Donatella, Bellati Filippo, Santini Daniele, Nuti Marianna, Rughetti Aurelia, Napoletano Chiara

Primary Institution: Policlinico Umberto I, Sapienza University of Rome, Rome, Italy

Hypothesis

This study aims to analyze the activating and inhibiting immune cells of NSCLC patients before and during therapy to identify patients who will benefit from immunotherapies.

Conclusion

Immunotherapy improved the immunological fitness of patients who benefited from treatment, shifting the immune balance towards activation.

Supporting Evidence

  • Immunotherapy significantly increased the levels of Ki67+ T cells and non-suppressive Tregs.
  • Responding patients showed a significant increase in Ki67+ and CD8+ T cells after the first treatment.
  • A low ratio of Tregs/CD137+ T cells correlated with a positive response to therapy.
  • Soluble PD1 levels increased after the first cycle of immunotherapy.

Takeaway

The study found that a type of treatment for lung cancer helps the body's immune system fight the cancer better, especially in patients who respond well to the treatment.

Methodology

The study analyzed immune cell changes in 48 NSCLC patients before and after the first cycle of immunotherapy using cytofluorimetry and Luminex assays.

Potential Biases

Potential biases may arise from the small sample size and the variability in treatment regimens.

Limitations

The study had a limited number of patients and treatment heterogeneity.

Participant Demographics

{"age":{"median":69.5,"under_75":35,"over_75":13},"sex":{"male":38,"female":10},"smoking_status":{"smokers":40,"non_smokers":8},"histotype":{"adenocarcinoma":38,"squamous":10}}

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1483182

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication